FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20240119E00197
1. Date of relevant event: 09/01/2024
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02453
4. Name of listed corporation: Concord Healthcare Group Co., Ltd. - H Shares 
5. Class of shares: H Shares 
6. Number of issued shares in class: 246,551,024
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) YANG
(Other names) Jianyu
10. Name of director (Chinese): 杨建宇 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1701Miscellaneous
On listing of the corporation or a class of shares of the listed corporation
 
 
 
         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
   
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position126,679,49051.38
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position126,679,490
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Morgancreek Investment Holdings LimitedP.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands; British Virgin IslandsYANG Jianyu100.00N
Long position126,679,490
Concord Medical Services Holdings LimitedScotia Centre, 4th Floor, P.O. Box 2804, George Town, Grand Cayman KY1-1112, Cayman Islands; Cayman IslandsMorgancreek Investment Holdings Limited72.30N
Long position126,679,490
Ascendium Group LimitedP.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands; British Virgin IslandsConcord Medical Services Holdings Limited100.00N
Long position126,679,490
Shanghai Medstar Financial Leasing Company LimitedRoom 116, 1/F, No. 56, Meisheng Road, Pilot Free Trade Zone, Shanghai, PRC; People's Republic of ChinaAscendium Group Limited98.19N
Long position58,277,190
Tianjin Concord Medical Technology Co., Ltd.K52. 11/F, Door 2, Block D, No. 1 Gonghua Road, Huayuan Industrial Zone, Binhai High Tech Zone, Tianjin, PRC; People's Republic of ChinaShanghai Medstar Financial Leasing Company Limited100.00Y
Long position28,115,800
Concord Hospital Management Group LimitedRoom 1701, 9 Chong Yip Street, Kwun Tong, Kowloon, Hong Kong; Hong KongAscendium Group Limited100.00N
Long position68,402,300
Beijing Concord Medical Technology Co., Ltd.Room 2702, Block A, No. 36, North Third Ring East Road, Dongcheng District, Beijing, PRC; People's Republic of ChinaConcord Hospital Management Group Limited100.00Y
Long position68,402,300
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Pursuant to the powers of attorney entered into by Shanghai Guanyou Enterprise Management Center (Limited Partnership) ("Shanghai Guanyou"), Changsheng Assets Co., Ltd. ("Changsheng Assets") and TIAN Yuan, Shanghai Medstar Financial Leasing Company Limited is deferred voting rights at the Shareholders' meetings of the Company and is therefore deemed to be interested in 14,383,300, 13,333,334 and 2,444,756 H Shares held by Shanghai Guanyou, Changsheng Assets and TIAN Yuan, respectively.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 19/01/2024
(dd/mm/yyyy)